Editorial: Medication safety in COVID-19 management, Volume II

被引：0

作者：

Das, Saibal ^{[1
,2
]}

机构：

[1] Indian Council Med Res, Ctr Ageing & Mental Hlth, Kolkata, India

[2] Karolinska Inst, Dept Global Publ Hlth, Stockholm, Sweden

来源：

关键词：

COVID-19; medication; pharmacovigilance; safety; vaccine;

D O I：

10.3389/fphar.2023.1175152

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页数：2

共 7 条

[1]

Centers for Disease Control and Prevention, 2023, Centers for Disease Control and Prevention

[2] Safety profile of COVID-19 drugs in a real clinical setting [J].

Chiu, Mei Nee ;

Bhardwaj, Maitry ;

Sah, Sangeeta Pilkhwal .

[3]

EMA, 2022, TREATM VACC COVID 19

[4] Time to Stop Using Ineffective Covid-19 Drugs [J].

Karim, Salim S. Abdool ;

Devnarain, Nikita .

Poland, Gregory A. ;

Ovsyannikova, Inna G. ;

Kennedy, Richard B. .

[6]

United States Food and Drugs Administration (US FDA), 2023, COR COVID 19 DRUGS 2

[7]

World Health Organization (WHO), 2022, THERCS COVID 19